Management of Obesity in Cardiovascular Practice: JACC Focus Seminar

Jean-Pierre Després1, André C Carpentier2, André Tchernof3

  • 1VITAM-Centre de recherche en santé durable, CIUSSS de la Capitale-Nationale, Québec, Québec, Canada; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Québec, Québec, Canada; Department of Kinesiology, Faculty of Medicine, Université Laval, Québec, Québec, Canada.

Insights

Obesity reduces life expectancy by increasing risks for type 2 diabetes and cardiovascular disease. Recognizing obesity as heterogeneous, not monolithic, is key to effective management and improved health outcomes.

Area of Science:

  • Endocrinology
  • Public Health
  • Cardiology

Background:

  • Obesity is a significant contributor to reduced life expectancy, primarily through its strong association with type 2 diabetes and cardiovascular diseases.
  • Despite its impact, obesity is often poorly diagnosed, ill-defined, and inadequately addressed as a modifiable risk factor in healthcare settings.

Purpose of the Study:

  • This review emphasizes the need to move beyond viewing obesity as a single entity.
  • It aims to highlight the heterogeneity of obesity in terms of its causes and health consequences.
  • The purpose is to guide more effective clinical and population-based strategies by differentiating patient subgroups.

Main Methods:

  • This is a review article, synthesizing existing literature and clinical observations.
  • It focuses on differentiating patient profiles within the spectrum of obesity.
  • The approach involves analyzing the distinct health issues associated with different obesity severities and fat distribution patterns.

Main Results:

  • Obesity is a heterogeneous condition, not a uniform disease.
  • Two key subgroups requiring distinct approaches are identified: individuals with excess visceral adipose tissue and those with severe obesity.
  • Severe obesity presents unique health challenges directly linked to excessive body fat mass.

Conclusions:

  • Treating all obesity as a single condition hinders effective management and contributes to discrepancies in care.
  • Personalized clinical approaches and population-based strategies are necessary to tackle high-cardiovascular-risk obesity.
  • The obesogenic environment and economy present significant compounding challenges to obesity management.

Related Concept Videos